BlackRock, Inc. - 30 Sep 2025 SCHEDULE 13G Report for CORVUS PHARMACEUTICALS INC Common Stock (CRVS)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: CORVUS PHARMACEUTICALS INC Common Stock
Symbol: CRVS
Shares outstanding: 74.4M shares
Disclosed Ownership: 4.02M shares
Ownership: 5.4%
Form type: SCHEDULE 13G
Filing time: 17 Oct 2025, 18:40:59 UTC
Date of event: 30 Sep 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	5.4%	4.02M	3.96M	0	Spencer Fleming	Managing Director